Ani pharmaceuticals inc (ANIP)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current Assets
Cash and cash equivalents

20,414

62,332

59,673

40,589

38,233

43,008

44,136

54,994

51,970

31,144

18,031

8,369

10,826

27,365

16,155

15,014

77,747

154,684

150,913

166,731

165,563

169,037

35,050

52,961

51,373

11,105

10,929

12,594

29,388

11

38,049

42,417

49,473

57,225

69,600

37,126

38,155

Accounts receivable, net of $104,771 and $59,946 of adjustments for chargebacks and other allowances at March 31, 2020 and December 31, 2019, respectively

82,379

72,129

70,700

76,274

67,410

64,842

67,647

56,115

54,801

58,788

62,174

55,513

46,697

45,895

47,477

35,562

22,481

21,932

21,645

18,880

17,371

17,297

14,570

7,794

10,907

12,513

9,515

6,427

-

5,432

-

-

-

-

-

-

-

Inventories, net

52,902

48,163

46,174

45,296

42,032

40,503

40,006

37,756

34,294

37,727

38,478

42,307

45,893

26,183

28,261

25,052

13,922

13,387

13,741

12,701

10,737

7,518

7,346

5,912

5,090

3,518

2,809

2,584

-

2,810

-

-

-

-

-

-

-

Prepaid income taxes

0

1,076

814

3,442

-

0

0

1,734

62

1,162

2,052

3,991

-

0

929

150

1,150

1,127

972

1,022

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax assets, net of valuation allowance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,266

7,999

7,776

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,967

3,995

5,025

3,311

4,157

4,524

5,004

1,768

2,267

2,784

4,847

2,676

3,565

3,564

2,653

4,046

1,252

1,453

1,985

1,615

1,546

1,139

599

493

566

580

580

251

277

313

534

512

716

801

943

1,013

2,469

Total Current Assets

158,662

187,695

182,386

168,912

151,832

152,877

156,793

152,367

143,394

131,605

125,582

112,856

106,981

103,007

95,475

79,824

116,552

192,583

197,522

208,948

202,993

194,991

57,565

67,160

67,936

27,716

26,094

24,118

31,926

8,566

38,583

42,929

50,190

58,026

70,543

38,139

40,625

Property and Equipment
Land

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

86

86

-

-

-

-

-

-

-

-

-

Buildings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,682

3,682

-

-

-

-

-

-

-

-

-

Machinery, furniture and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,736

3,724

-

-

-

-

-

-

-

-

-

Construction in progress

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

176

-

-

-

-

-

-

-

-

-

Property, Plant and Equipment, Gross, Total

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,703

7,669

-

-

-

-

-

-

-

-

-

Less: accumulated depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,062

2,928

-

-

-

-

-

-

-

-

-

Property and equipment, net

40,353

40,551

39,754

38,953

38,425

38,090

37,418

22,842

21,882

20,403

17,387

14,966

12,897

10,998

9,716

8,911

8,415

7,131

5,833

5,249

5,281

5,223

5,046

4,625

4,518

4,537

4,640

4,740

-

4,880

1,184

862

884

861

854

1,132

635

Restricted cash

5,002

5,029

5,025

5,018

5,008

5,021

5,014

5,007

5,002

5,006

5,004

5,002

5,001

5,002

5,001

5,001

-

0

-

-

-

-

-

-

-

-

2,260

2,260

2,260

-

-

-

-

-

-

-

-

Deferred tax assets, net of deferred tax liabilities and valuation allowance

57,906

38,326

36,002

31,957

28,542

27,964

25,082

23,590

23,163

22,667

30,829

27,933

26,962

26,227

18,400

17,751

17,397

17,316

7,118

7,027

7,369

15,439

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,674

2,885

3,096

-

-

-

-

0

0

0

-

217

-

-

-

-

-

-

-

Intangible assets, net

215,619

180,388

188,372

196,697

205,100

201,604

209,544

217,484

221,917

229,790

189,829

196,624

203,459

175,792

188,949

194,674

147,386

66,397

68,291

44,174

45,408

42,067

43,188

21,800

22,360

10,409

10,712

10,960

-

85

-

-

-

-

-

-

-

Goodwill

3,580

3,580

3,580

3,580

3,580

3,580

4,180

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

1,838

-

0

-

-

-

-

-

-

-

Other non-current assets

1,110

1,220

1,656

1,789

1,903

1,468

1,412

1,049

823

829

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

12,550

12,798

-

-

-

-

-

-

-

-

-

Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,413

-

3,413

3,413

3,413

3,405

3,405

3,405

3,405

Deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

-

30

88

86

86

86

86

99

Total Assets

482,232

456,789

456,775

446,906

434,390

430,604

439,443

424,177

418,019

412,138

370,469

359,219

357,138

322,864

319,379

307,999

291,588

285,265

283,276

270,121

265,985

259,558

107,637

95,423

96,652

44,500

43,285

41,658

35,356

13,748

43,211

47,294

54,574

62,379

74,890

42,763

44,766

Liabilities and Stockholders' Equity
Current Liabilities
Current debt, net of deferred financing costs

11,872

9,941

4,154

4,149

3,243

3,256

5,692

5,217

3,805

3,353

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible Notes, net of discount and deferred financing costs

-

-

-

-

-

112,463

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible Debt Current Excluding Deferred Financing Costs

-

-

117,586

115,858

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes, net of discount and deferred financing costs

-

-

-

-

114,150

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

12,485

14,606

10,953

9,809

10,519

8,884

7,257

7,949

4,886

3,630

5,821

3,153

4,785

3,389

4,730

4,961

3,040

2,066

2,633

1,325

2,288

2,654

3,059

1,731

2,660

1,429

2,086

1,634

164

1,994

2,004

3,835

3,281

3,150

6,041

6,348

4,864

Accrued expenses and other

4,378

2,362

3,368

2,423

3,074

1,707

2,818

1,863

2,612

1,571

2,741

1,565

2,087

927

2,016

770

1,727

617

2,221

1,170

1,897

567

3,888

1,133

1,013

327

1,338

1,039

112

927

860

1,028

2,035

2,479

2,747

2,872

1,681

Accrued royalties

6,285

5,084

5,527

6,265

5,440

8,456

7,455

8,219

11,361

12,164

11,741

11,255

10,331

11,956

11,769

8,110

4,632

606

-

-

-

702

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued compensation and related expenses

3,151

3,736

3,494

2,133

2,454

3,524

2,773

1,410

1,495

2,306

2,009

1,227

1,135

1,631

1,426

1,071

722

1,188

1,019

844

513

1,348

-

-

-

773

2,535

2,726

879

-

463

1,031

767

1,597

1,476

1,072

526

Current income taxes payable, net

15,223

0

0

0

3,453

5,022

318

-

-

0

0

0

3,656

2,398

-

-

-

0

0

0

481

4,253

-

-

-

20

-

-

-

-

-

-

-

-

-

-

-

Accrued government rebates

8,030

8,901

9,184

10,943

8,552

8,974

9,014

5,256

6,471

7,930

5,755

3,534

4,655

5,891

-

-

-

4,631

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued Medicaid rebates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,451

6,509

3,424

-

4,428

1,891

2,077

2,264

-

-

-

253

-

-

-

-

-

-

-

-

-

-

-

Returned goods reserve

17,614

16,595

15,945

14,656

13,559

12,552

10,840

9,764

9,020

8,274

8,317

7,558

5,776

5,756

4,099

3,309

2,666

2,648

1,889

1,719

1,817

1,445

1,178

951

849

736

457

349

-

411

-

-

-

-

-

-

-

Deferred revenue

318

451

496

558

624

711

735

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

20

13

38

-

46

46

-

315

-

-

-

-

-

-

-

Borrowings under line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

4,065

-

-

-

-

-

-

-

Current liabilities, discontinued operation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

131

366

-

-

-

-

-

-

-

-

-

Total Current Liabilities

79,356

61,676

170,707

166,794

165,068

165,549

46,902

39,678

39,650

39,228

36,384

28,292

32,425

31,948

30,491

24,730

16,211

11,756

12,190

6,949

9,073

13,233

8,145

3,828

4,560

3,538

6,597

6,163

-

7,712

10,922

16,373

6,084

7,227

11,499

11,481

8,183

Non-current Liabilities
Long-term royalties

-

-

-

-

-

-

-

-

-

-

0

0

0

625

1,250

2,500

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-current debt, net of deferred financing costs and current component

188,094

175,808

64,873

65,688

66,501

67,296

65,954

67,262

68,569

69,946

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings on line of credit

-

-

-

-

-

-

-

-

-

-

25,000

30,000

30,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes, net of discount and deferred financing costs

-

-

-

-

-

-

134,122

132,127

130,156

128,208

126,284

124,381

122,501

120,643

118,808

116,993

115,199

113,427

115,193

113,672

112,172

106,540

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

13,611

6,514

8,065

6,768

3,109

496

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of convertible senior notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,169

-

7,593

10,477

-

-

1,234

1,187

1,111

Long-term Convertible Senior Notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,493

17,336

19,242

19,751

17,436

Total Liabilities

281,061

243,998

243,645

239,250

234,678

233,341

246,978

239,067

238,375

237,382

187,668

182,673

184,926

153,216

150,549

144,223

131,410

125,183

127,383

120,621

121,245

119,773

-

-

-

3,538

-

-

9,325

-

10,922

16,373

16,578

24,564

30,742

31,233

25,619

Commitments and Contingencies (Note 11)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

Stockholders' Equity
Common Stock, $0.0001 par value, 33,333,334 shares authorized; 12,111,833 shares issued and 12,083,963 outstanding at March 31,2020; 12,104,875 shares issued and 12,089,565 shares outstanding at December 31, 2019

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

Class C Special Stock, $0.0001 par value, 781,281 shares authorized; 10,864 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Preferred Stock, $0.0001 par value, 1,666,667 shares authorized; 0 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

Treasury stock, 27,870 shares of common stock, at cost, at March 31, 2020 and 15,310 shares of common stock, at cost, at December 31, 2019

1,211

723

723

723

0

659

659

659

250

259

259

259

-

0

-

-

-

-

0

113

0

-

0

0

68

68

432

432

-

0

-

-

-

-

-

-

-

Additional paid-in capital

203,505

200,800

197,470

194,867

189,971

186,812

186,532

184,531

181,649

179,020

177,436

175,901

173,989

172,563

170,665

168,154

165,681

164,431

163,118

161,397

160,095

159,509

140,221

139,070

137,272

89,501

89,024

89,021

-

1,083

-

-

-

-

-

-

-

Capital stock
Capital stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

273,278

-

273,259

265,768

265,500

255,054

254,739

209,387

184,777

Retained earnings

10,565

17,584

22,419

18,524

11,939

11,488

6,058

1,021

-1,756

-4,006

5,623

903

-1,778

-2,916

-1,836

-4,379

-5,504

-4,350

-7,226

-11,785

-15,356

-19,725

-40,730

-47,476

-45,113

-48,472

-51,904

-53,095

-247,247

-43,798

-240,969

-234,847

-227,503

-217,239

-210,590

-197,856

-165,630

Accumulated other comprehensive loss, net of tax

-11,689

-4,871

-6,037

-5,013

-2,199

-379

533

216

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Stockholders' Equity

201,171

212,791

213,130

207,656

199,712

197,263

192,465

185,110

179,644

174,756

182,801

176,546

172,212

169,648

168,830

163,776

160,178

160,082

155,893

149,500

144,740

139,785

99,492

91,595

92,092

40,962

36,688

35,494

26,030

-42,715

32,289

30,921

37,996

37,815

44,148

11,530

19,147

Total Liabilities and Stockholders' Equity

482,232

456,789

456,775

446,906

434,390

430,604

439,443

424,177

418,019

412,138

370,469

359,219

357,138

322,864

319,379

307,999

291,588

285,265

283,276

270,121

265,985

259,558

107,637

95,423

96,652

44,500

43,285

41,658

35,356

13,748

43,211

47,294

54,574

62,379

74,890

42,763

44,766